Prism Biotech

Private

SF-based biotech building AI-designed protein-language-model targeted therapies for cardiovascular disease.

Founders James Kim

CEO James Kim

Company

Founded

2023

Headquarters

San Francisco, United States

Financials

Total Funding

$55M

Sectors

Artificial Intelligence Biotech

prismbiotech.com

Funding History

2 rounds

Series A Aug 19, 2026

$44M

Third Rock Ventures (Lead) ARCH Venture Partners Flagship Pioneering

Seed Feb 20, 2024

$11M

ARCH Venture Partners (Lead) Third Rock Ventures

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.